Company Ion Beam Applications, SA
Equities
IBAB
BE0003766806
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.24 EUR | +1.22% | -3.64% | +14.73% |
Mar. 21 | Transcript : Ion Beam Applications SA, 2023 Earnings Call, Mar 21, 2024 | |
Mar. 21 | Ion Beam Applications SA Reports Earnings Results for the Full Year Ended December 30, 2023 | CI |
Business Summary
- diagnosis and therapeutic treatment equipment and systems (85.1%): proton therapy equipment (71.2% of net sales; No. 1 worldwide), and particle accelerators (28.8%) used in the production of radioisotopes (cyclotrons) and in the development of sterilization and ionization solutions (Rhodotron® and Dynamitron®);
- equipment and solutions of dosimetry (14.9%; No. 1 worldwide): measurement and analysis tools of the radiation doses in medical imaging and radiation therapy.
Net sales are distributed geographically as follows: Belgium (1.2%), the United States (35.3%) and other (63.5%).
Number of employees: 2,000
Sales per Business
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Proton Therapy and Other Accelerators
85.1
%
| 261 | 83.3 % | 307 | 85.1 % | +17.90% |
Dosimetry
14.9
%
| 52 | 16.7 % | 54 | 14.9 % | +3.14% |
Sales per region
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Rest of the World
63.5
%
| 225 | 72.0 % | 229 | 63.5 % | +1.77% |
United States
35.4
%
| 82 | 26.2 % | 128 | 35.4 % | +55.77% |
Belgium
1.2
%
| 6 | 1.8 % | 4 | 1.2 % | -24.98% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Olivier Legrain
CEO | Chief Executive Officer | 56 | 95-12-31 |
Yves Jongen
FOU | Founder | 76 | 86-03-27 |
Director of Finance/CFO | 46 | 03-12-31 | |
Pierre Mottet
CHM | Chairman | 63 | 86-12-31 |
Christian Matton
IRO | Public Communications Contact | - | - |
Frédéric Nolf
HRO | Human Resources Officer | 53 | 06-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Pierre Mottet
CHM | Chairman | 63 | 86-12-31 |
Hedvig Hricak
BRD | Director/Board Member | 77 | 17-04-30 |
Yves Jongen
FOU | Founder | 76 | 86-03-27 |
Olivier Legrain
CEO | Chief Executive Officer | 56 | 95-12-31 |
Richard Hausmann
BRD | Director/Board Member | 64 | 20-08-31 |
Marcel Miller
BRD | Director/Board Member | 71 | 11-04-30 |
Director/Board Member | - | 15-04-30 | |
Christine Dubus
BRD | Director/Board Member | 60 | 20-08-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 30,282,218 | 19,948,646 ( 65.88 %) | 1,162,754 ( 3.840 %) | 65.88 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
1,162,754 | 3.84% | 16,450,644 $ |
Company contact information
Ion Beam Applications SA
3, chemin du Cyclotron
1348, Louvain-la-Neuve
+32 1 047 58 11
http://www.iba-worldwide.comGroup companies
Name | Category and Sector |
---|---|
IBA Investments SCRL
| |
IBA Dosimetry GmbH
IBA Dosimetry GmbH Medical SpecialtiesHealth Technology Part of Ion Beam Applications SA, IBA Dosimetry GmbH is a German company that offers a full range of innovative high-quality solutions to maximize efficiency and minimize errors in radiation therapy and medical imaging. The private company is based in Schwarzenbruck, Germany. IBA Dosimetry specializes in 3D Water Phantom System for complete LINAC Commissioning & QA with unique absolute measurement technology. The company also provides advanced beam verification and quality assurance for all x-ray imaging modalities. The CEOs of the company are Soumya Chandramouli, Olivier Legrain, Jean-Marc Bothy. |
Medical Specialties
|
Sector
Sales per Business
Sales per region
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+14.73% | 412M | |
+2.02% | 207B | |
+2.17% | 175B | |
+10.45% | 132B | |
+16.62% | 99.1B | |
-2.70% | 60.89B | |
+13.38% | 52.04B | |
-6.33% | 45.48B | |
-4.74% | 38.81B | |
+9.89% | 38.77B |
- Stock Market
- Equities
- IBAB Stock
- Company Ion Beam Applications, SA